Literature DB >> 11960070

Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease.

Martijn R van de Scheur1, Rutger I F van der Waal, Ad A van Bodegraven, Hennie J Völker-Dieben, Theo M Starink, Isaäc van der Waal.   

Abstract

Crohn's disease can be accompanied by extraintestinal manifestations. The authors report on a 39-year-old patient who presented with cheilitis granulomatosa as the first manifestation of Crohn's disease. Four years later, intestinal Crohn's disease was diagnosed. One year afterward, acute loss of visual acuity from optic neuropathy developed as another rare extraintestinal manifestation of Crohn's disease.

Entities:  

Mesh:

Year:  2002        PMID: 11960070     DOI: 10.1097/00004836-200205000-00016

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease.

Authors:  Philippe Eloy; E Leruth; Y Goffart; M C Nollevaux; V Fridman; M Dartevelle; M Melange; J Daele; B Bertrand
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

2.  Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Alexandre; Yves Vandermeeren; Olivier Dewit; Tom Moreels; Nanne de Boer; Anjan Dhar; Chris Ziady; Ariella Bar-Gil Shitrit; Flavio Steinwurz; Njegica Jojic; Giuseppe Costantino; Benoit Bihin; Jean-François Rahier; Konstantinos H Katsanos
Journal:  J Crohns Colitis       Date:  2016-01-12       Impact factor: 9.071

Review 3.  [Neurological complications of inflammatory bowel diseases].

Authors:  N Cieplik; M Stangel; O Bachmann
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

4.  Inflammatory bowel disease: an increased risk factor for recurrent laryngeal nerve palsy in thyroid surgery.

Authors:  G Caruso; E Benicchi; C Ciuoli; F M Passali; D Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-04       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.